Compare two surgery methods for early prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial compares two ways of treating localized prostate cancer: H-FIRE versus laparoscopic prostate surgery. It may help find which approach works best for people with early-stage, non-spread prostate cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under 80 years old.
- Your PSA blood test is under 20 ng/mL.
- Your cancer is limited to the prostate (stage T2c or less) and has not spread.
- Your biopsy Gleason score is 4+4 or lower.
- You understand the study and can sign informed consent.
- You have not had any treatment for prostate cancer before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares focal HIFU (a targeted heating treatment inside the prostate) with prostate surgery, looking at overall cost and quality of life. It may help people with certain early, limited prostate cancers understand which option fits best for them.
This trial tests a laser treatment that targets only the cancerous part of the prostate. It may be an option for men with intermediate-risk prostate cancer who do not want their entire prostate removed.
This trial tests a gentler treatment called focal therapy that targets only the part of the prostate with cancer. It's for men whose prostate cancer has a Gleason score of 7, low PSA, and hasn't spread outside the prostate.
This trial compares two standard treatments for prostate cancer that hasn't spread: surgery to remove the prostate (radical prostatectomy) and radiation therapy (curative radiotherapy). It looks back at past patients to see which treatment worked better.
This trial tests whether targeting only the visible cancer spots on MRI (focal therapy) works as well as treating the whole prostate, for men with small, moderate-risk prostate cancer that hasn't spread.
This study is tracking men who choose focal therapy (a targeted treatment) for their localized prostate cancer. It aims to learn how well this treatment works and how it affects quality of life.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.